Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05364606 · ClinicalTrials.gov registry record
Patient Specific Talus Spacer Post Approval Study
A clinical trial of Avascular Necrosis of the Talus, sponsored by Paragon 28.
- Recruiting
- Registry status
- 50
- Enrollment target
- 6
- Study locations
NCT05364606 is a study of Avascular Necrosis of the Talus that is actively recruiting participants, run by Paragon 28. The registered enrollment target is 50 participants. The trial reports 6 study locations across 6 states.
The verdict
NCT05364606, a study of Avascular Necrosis of the Talus, is actively recruiting participants, sponsored by Paragon 28.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 6
- Study locations
Study Summary
Humanitarian Device Exemption Approved Patient Specific Talus Spacer Post Approval Study.
Conditions Studied
Interventions
- DEVICE Patient Specific Talus Spacer
Study Locations (6)
California
- Redwood Orthopaedics - Santa Rosa
Indiana
- Fort Wayne Orthopedics - Fort Wayne
Maryland
- Mercy Institute for Foot & Ankle Reconstruction - Baltimore
North Carolina
- Duke Orthopeadics Arringdon - Morrisville
South Carolina
- Medical University of South Carolina - Charleston
Texas
- UT Physicians Orthopedics - Pearland - Pearland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-07-08 |
| Est. Completion | 2029-11-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05364606
The ClinicalTrials.gov registry entry for NCT05364606 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Paragon 28, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Avascular Necrosis of the Talus appearing as the primary indexed condition, and to 1 intervention - of which Patient Specific Talus Spacer is the first listed.
NCT05364606 reports 6 study locations spanning 6 distinct geographic areas - top geographies include California, Indiana, Maryland.
Frequently Asked Questions
What is clinical trial NCT05364606 about?
NCT05364606 is a clinical study titled "Patient Specific Talus Spacer Post Approval Study". Humanitarian Device Exemption Approved Patient Specific Talus Spacer Post Approval Study.
What is the current status of trial NCT05364606?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2022-07-08. Estimated completion is 2029-11-30.
What conditions does trial NCT05364606 study?
This clinical trial studies the following conditions: Avascular Necrosis of the Talus.
What interventions are being tested in trial NCT05364606?
The interventions under investigation include: Patient Specific Talus Spacer (DEVICE).
Who is sponsoring clinical trial NCT05364606?
This trial is sponsored by Paragon 28, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05364606 being conducted?
This trial has 6 study locations across California, Indiana, Maryland, North Carolina, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Avascular Necrosis of the Talus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.